Family Medicine Doctors in Scotch Plains, NJ Accepting Medicare

6 Family Medicine doctors found. Showing 1 - 6

Dr. Payal Joshi, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 E 2nd St, Scotch Plains, NJ 07076 Phone: 908-322-7786

Constance Delio, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1801 E 2nd St, Scotch Plains, NJ 07076 Phone: 908-322-7786

Dr. Darren S Chin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1765 E 2nd St, Scotch Plains, NJ 07076 Phone: 908-322-2490    Fax: 888-364-8160

Dr. Nicholas A. Cunicella Iii, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2314 South Ave, Scotch Plains, NJ 07076 Phone: 908-233-6660    Fax: 908-654-7152

Pooja Mehta, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1814 E 2nd St # 4, Scotch Plains, NJ 07076 Phone: 908-322-6611    Fax: 908-322-8665

Dr. Arnold M Roth, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1814 E 2nd St, Scotch Plains, NJ 07076 Phone: 908-322-6611    Fax: 908-322-8665

News Archive

Scientists study the impact of nerve growth factors for treating Parkinson's disease

Scientists in the Academy of Finland's Neuroscience Research Programme have reported promising new results with potential implications for the treatment of Parkinson's disease. They have been studying the impacts of nerve growth factors in the treatment of PD, and their latest results show that a certain growth factor can be used to halt the progress of damage brought on by a nerve poison and possibly even restore the function of damaged cells.

Low-income families having children with special health care needs at high risk for food insecurity

Low-income families with children who have special health care needs are at high risk for food insecurity, even when they receive Supplemental Security Income (SSI) and participate in public assistance programs, such as Supplemental Nutrition Assistance Program (SNAP) and Women, Infants, and Children (WIC).

Researchers reconstruct 3D models of neuronal networks for studying cortex organization

Researchers at the Max Planck Institute for Biological Cybernetics (Germany), VU University Amsterdam (Netherlands) and Max Planck Florida Institute for Neuroscience (USA) succeed in reconstructing the neuronal networks that interconnect the elementary units of sensory cortex - cortical columns.

Scientists identify compound to inhibit wild-type HIV-1 protease

Drug resistance remains a major problem in combating HIV infection, but a different approach to drug development could be the answer.Current viral inhibitors target the HIV-1 protease function with a competitive mechanism. Writing in the BJ ChemBio Knowledge Environment of the Biochemical Journal, Max Chang and colleagues from the Scripps Research Institute, La Jolla, suggest that pharmaceutical companies look at compounds that use an allosteric non-competitive mechanism of inhibition.

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

K.U.Leuven announced today that on July 29th, 2010 they entered into a license agreement with Pfizer. The license agreement grants Pfizer exclusive and sublicenseable worldwide rights to further develop and commercialise K.U.Leuven's compounds with a new mechanism of action for the potential treatment of individuals infected with HIV, the virus that causes AIDS.

Read more Medical News

› Verified 4 days ago